Vaxcyte Share Holder Equity 2019-2024 | PCVX

Vaxcyte share holder equity for the quarter ending September 30, 2024 was $3.418B, a 143.64% increase year-over-year.

  • Vaxcyte share holder equity for 2023 was $1.24B, a 30.08% increase from 2022.
  • Vaxcyte share holder equity for 2022 was $0.954B, a 235.76% increase from 2021.
  • Vaxcyte share holder equity for 2021 was $0.284B, a 17.88% decline from 2020.

Vaxcyte Share Holder Equity 2019-2024 | PCVX

  • Vaxcyte share holder equity for 2023 was $1.24B, a 30.08% increase from 2022.
  • Vaxcyte share holder equity for 2022 was $0.954B, a 235.76% increase from 2021.
  • Vaxcyte share holder equity for 2021 was $0.284B, a 17.88% decline from 2020.